lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
226 rows where filing_period = "second_quarter", filing_year = 2013 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1401276 | PARRY, ROMANI, DECONCINI & SYMMS 22cf9f9b-6729-4ca8-8839-7b4d2c58d19f | 2T | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2013 | second_quarter | MED | Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2013-05-20T16:11:08.293000-04:00 | ||
| 1401280 | PARRY, ROMANI, DECONCINI & SYMMS 62a95ebf-7a7c-45a2-83b0-2db37e871756 | 2T | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2013 | second_quarter | MED | Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2013-05-20T16:20:10.977000-04:00 | ||
| 1401284 | PARRY, ROMANI, DECONCINI & SYMMS 997802ff-308f-43af-8df5-bbef2d10ffc3 | 2T | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2013 | second_quarter | MED | Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2013-05-20T16:34:13.347000-04:00 | ||
| 1401290 | PARRY, ROMANI, DECONCINI & SYMMS 784014c6-1a40-482c-9cc6-cc890ab5188b | 2T | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2013 | second_quarter | MED | Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2013-05-20T16:45:15.340000-04:00 | ||
| 1401310 | PARRY, ROMANI, DECONCINI & SYMMS 97180f1b-de8b-4e10-9e7c-456baf7320eb | 2T | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2013 | second_quarter | MED | Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2013-05-20T17:05:18.880000-04:00 | ||
| 1401601 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 5aa2945d-ad75-49fa-b7dd-634dc5f9ddeb | 2A | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 1375 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2013 | second_quarter | MED | Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2013-06-05T14:06:36.930000-04:00 | ||
| 1401723 | CHARLIE MCBRIDE ASSOCIATES 5b60f187-152a-4385-9dd8-8dc56a98d97c | Q2 | CHARLIE MCBRIDE ASSOCIATES | 24214 | BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA | 2013 | second_quarter | MED | To monitor legislation affecting medical energy research and technology-based economic development | HOUSE OF REPRESENTATIVES,SENATE | 7200 | 0 | 0 | 2013-06-19T09:52:05.830000-04:00 | |
| 1401732 | COLBY & COMPANY 1c90bb0c-d9b0-4b3d-9dbb-4fe9b8b0e251 | Q2 | COLBY & COMPANY | 400394858 | BIOOHIO | 2013 | second_quarter | MED | Urge repeal of medical device tax | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-06-19T15:12:06.920000-04:00 | ||
| 1401741 | CHARLIE MCBRIDE ASSOCIATES 019c8cf5-aa8d-4a9d-b516-c68cd1256788 | 2A | CHARLIE MCBRIDE ASSOCIATES | 24214 | BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA | 2013 | second_quarter | MED | To monitor legislation affecting medical energy research and technology-based economic development | HOUSE OF REPRESENTATIVES,SENATE | 7200 | 0 | 0 | 2013-06-20T10:55:23.440000-04:00 | |
| 1401832 | PALMETTO GROUP dee33fbc-d954-4181-98ab-2b436e71c264 | Q2 | PALMETTO GROUP | 18570 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2013 | second_quarter | MED | Federal Funding of AIDS vaccine Department of State, Foreign Operations, and Related Programs Appropriations Act, 2014 | SENATE | 22500 | 0 | 0 | 2013-06-27T11:10:22.397000-04:00 | |
| 1401953 | MARSHALL BRACHMAN 0724a715-da5e-4aec-a4b1-60a6152e8400 | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2013 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2013-07-01T00:31:34.430000-04:00 | |
| 1402064 | DALRYMPLE & ASSOCIATES, LLC 40e23c88-9060-4589-9914-9978074402f3 | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2013 | second_quarter | MED | Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2013-07-01T14:48:26.817000-04:00 | |
| 1402072 | DALRYMPLE & ASSOCIATES, LLC dad5fd86-1e44-4f5a-814f-4280b173ae97 | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | SANOFI PASTEUR | 2013 | second_quarter | MED | Vaccine research and development legislation, funding, appropriations and oversight. | Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office | 46000 | 0 | 0 | 2013-07-01T15:30:30.970000-04:00 | |
| 1402297 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) c8718f45-8365-4fba-80ed-139390f0a5bc | Q2 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | VIJUK EQUIPMENT, INC. | 2013 | second_quarter | MED | all matters dealing with pharmaceutical labeling | Food & Drug Administration (FDA) | 25000 | 0 | 0 | 2013-07-02T13:17:35.603000-04:00 | |
| 1402381 | ASSN OF MEDICAL DEVICE REPROCESSORS 23d0445c-8fca-4231-add5-a91ce0774bb5 | Q2 | ASSN OF MEDICAL DEVICE REPROCESSORS | 291732 | ASSN OF MEDICAL DEVICE REPROCESSORS | 2013 | second_quarter | MED | Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Contacted VA and House and Senate about regulations for reprocessed single-use medical devices. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2013-07-02T14:51:16.777000-04:00 | ||
| 1402389 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 452ecc49-8bd4-45e7-b2c4-f7e120002f03 | 2T | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | PATH | 2013 | second_quarter | MED | Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2013-07-02T14:54:20.370000-04:00 | |
| 1402454 | AMERICAN COLLEGE OF CLINICAL PHARMACY 4670cda4-d6af-4311-b1bd-61e74dbf7a6a | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2013 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 111725 | 0 | 0 | 2013-07-02T16:07:53.320000-04:00 | |
| 1402971 | FRANCIS EDWARD & CRONIN, INC. 94424604-238f-4d75-a555-3838deaf0c7e | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | AMERICAN BRAIN TUMOR ASSOCIATION | 2013 | second_quarter | MED | Issues and legislation related to brain tumors and brain tumor research. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office | 10000 | 0 | 0 | 2013-07-05T15:08:26.990000-04:00 | |
| 1402973 | FRANCIS EDWARD & CRONIN, INC. 1370b257-b431-4cea-b064-3c62b2d8503b | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2013 | second_quarter | MED | Legislation and issues related to Alzheimer's Disease Research | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office | 10000 | 0 | 0 | 2013-07-05T15:14:28.890000-04:00 | |
| 1403235 | UNIVERSITY OF IOWA 8bb0490d-8531-450f-8557-c87606ae1355 | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2013 | second_quarter | MED | FY 2012 Appropriations Residency Caps Minority Improvement NIOSH Education and Research Centers for Occupational Health and SafetyPrevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations FY 2014 Appropriations | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT) | 29312 | 0 | 0 | 2013-07-08T12:52:43.863000-04:00 | |
| 1403809 | FEDERAL SOLUTIONS, LLC abcae3ae-d48b-480e-8ef8-74d66e185031 | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | JACKSONVILLE STATE UNIVERSITY | 2013 | second_quarter | MED | Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research, education, and development | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-07-09T16:01:34.570000-04:00 | |
| 1403823 | FEDERAL SOLUTIONS, LLC 24f00c8b-42df-4322-90a0-bfc3b47d6487 | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2013 | second_quarter | MED | Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research | Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2013-07-09T16:05:38.377000-04:00 | |
| 1404046 | THE CJR GROUP, INC. b103747f-330f-46da-a57d-5c8967aadc96 | Q2 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2013 | second_quarter | MED | Medical issues relating to hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-10T11:25:29.707000-04:00 | |
| 1404277 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 4de74c96-248c-4210-bc95-7cd406dc1558 | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2013 | second_quarter | MED | NIH Budget including Title VII & VIII programs-Sequestration | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 145000 | 0 | 0 | 2013-07-10T14:23:46.640000-04:00 | |
| 1404640 | HARRISON RIVARD DUNCAN & BUZZETT, CHTD. f5f2e7f7-6d54-429c-96a3-2e4607520f8b | Q2 | HARRISON RIVARD DUNCAN & BUZZETT, CHTD. | 72257 | HCA HEALTHCARE | 2013 | second_quarter | MED | Health and Medical Issues | 0 | 0 | 2013-07-11T10:17:52.227000-04:00 | |||
| 1404796 | LNE GROUP 837428c3-5f0d-4695-a826-5f04ac50761e | Q2 | LNE GROUP | 308811 | GOJO INDUSTRIES | 2013 | second_quarter | MED | Lobbied on issues regarding medical industry | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-11T11:55:07.697000-04:00 | |
| 1404808 | LNE GROUP 1a4919b1-8c69-4be0-b3f4-28eea72499a7 | Q2 | LNE GROUP | 308811 | OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) | 2013 | second_quarter | MED | Lobbied for issues within the medical field including reseach, and clinical labs | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-11T12:00:13.973000-04:00 | |
| 1404909 | LNE GROUP 4b7bafcc-e48a-4c33-81dc-14a23b2acfe7 | Q2 | LNE GROUP | 308811 | INTRINSIQ MATERIALS | 2013 | second_quarter | MED | Lobbied for issues regarding the medical research | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-11T12:48:43.403000-04:00 | |
| 1404965 | LNE GROUP 7004c4d4-183c-42af-b6c7-e43cea4738fb | Q2 | LNE GROUP | 308811 | PARKER HANNIFIN | 2013 | second_quarter | MED | Lobbied on issues regarding the medical field/disease research/clinical labs | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2013-07-11T13:11:02.493000-04:00 | |
| 1405005 | LNE GROUP 3d83962d-9d8f-40ad-85c4-56e90bdd76dc | Q2 | LNE GROUP | 308811 | ZIMMER | 2013 | second_quarter | MED | Lobbied for medical device issues. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-11T13:30:13.010000-04:00 | |
| 1405115 | MASSACHUSETTS MEDICAL SOCIETY 0b38c9dc-2823-4137-9aa0-2e81237feec1 | Q2 | MASSACHUSETTS MEDICAL SOCIETY | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 2013 | second_quarter | MED | Reclassification of marijuana so that its potential medicinal use by humans may be studied and potentially regulated by the FDA | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE | 60000 | 0 | 0 | 2013-07-11T14:58:10-04:00 | |
| 1405134 | MCDERMOTT WILL & SCHULTE LLP e5add7ca-188f-4919-863b-f9043eef2686 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | GENOMIC HEALTH INC | 2013 | second_quarter | MED | FDA regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-11T15:05:17.247000-04:00 | |
| 1405226 | PARRY, ROMANI, DECONCINI & SYMMS e81b1070-989b-4d91-8167-c9dcbed73d37 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2013 | second_quarter | MED | Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014. Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-11T16:00:55.187000-04:00 | |
| 1405702 | GRIZZLE COMPANY 8f3968c1-3393-4162-9654-fde198e222a9 | Q2 | GRIZZLE COMPANY | 16987 | UNIVERSITY OF LOUISVILLE | 2013 | second_quarter | MED | Support for PICORI grant application. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-07-12T13:52:19.177000-04:00 | |
| 1405729 | DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO 576d254c-3cff-40b1-adce-2100df8785cb | Q2 | DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO | 12094 | DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO | 2013 | second_quarter | MED | Strategies to Address Antimicrobial Resistance Act (H.R. 2285). | Commerce, Dept of (DOC),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Endowment for the Arts,SENATE,U.S. International Trade Commission (ITC) | 30000 | 0 | 0 | 2013-07-12T14:05:27.683000-04:00 | |
| 1405967 | MCDERMOTT WILL & SCHULTE LLP 59c68b6b-0506-4330-9d9d-f73943d12479 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | COALITION FOR 21ST CENTURY MEDICINE | 2013 | second_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2013-07-12T15:57:38.157000-04:00 | |
| 1406222 | THE PETRIZZO GROUP, INC. 6e585274-f1bf-4f64-8229-84850b4590e0 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2013 | second_quarter | MED | Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. Support for full funding of NIH | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 20000 | 0 | 0 | 2013-07-13T10:06:57.010000-04:00 | |
| 1406229 | BEN BARNES GROUP LP 10dfddcf-ed87-4467-a6ae-8df7a5404a05 | Q2 | BEN BARNES GROUP LP | 5415 | FAIR LABORATORY PRACTICES ASSOCIATION | 2013 | second_quarter | MED | Bring attention to prevention of unfair billing practices by laboratories for Medicare services | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-07-13T11:31:01.467000-04:00 | ||
| 1406251 | BEN BARNES GROUP LP b8bc5ebe-8908-4f6a-be06-aec281cc06e2 | Q2 | BEN BARNES GROUP LP | 5415 | ROYALTY PHARMA - / RP MANAGEMENT, LLC | 2013 | second_quarter | MED | Tax Reform, Master Limited Partnership | HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2013-07-13T13:38:15.930000-04:00 | |
| 1406267 | BEN BARNES GROUP LP 9de656e7-9fc3-4ce8-957a-9cabf730f2ba | Q2 | BEN BARNES GROUP LP | 5415 | TEXAS A&M SYSTEM | 2013 | second_quarter | MED | Assost the Texas A&M System in pursuit of various projects, general government relations | HOUSE OF REPRESENTATIVES,SENATE | 37500 | 0 | 0 | 2013-07-13T14:05:19.217000-04:00 | |
| 1406336 | THE PETRIZZO GROUP, INC. 9e205ce0-7f62-4028-a1e0-5e2c25a3dd81 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2013 | second_quarter | MED | Advocate for federal funding for reaserch on traumatic brain injury, PTSD, and treatment of bleeding during surgery and trauma. | Defense, Dept of (DOD) | 30000 | 0 | 0 | 2013-07-14T12:12:09.070000-04:00 | |
| 1406370 | THE PETRIZZO GROUP, INC. 568f807a-8d43-4fe5-926d-6a322ed97e0f | Q2 | THE PETRIZZO GROUP, INC. | 305932 | FRED HUTCHINSON CANCER RESEARCH CENTER | 2013 | second_quarter | MED | Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding. Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-14T16:40:27.997000-04:00 | |
| 1406768 | AMERICAN SOCIETY FOR MICROBIOLOGY 6e4c3883-716f-4ed1-a1eb-362a6b86ddc8 | Q2 | AMERICAN SOCIETY FOR MICROBIOLOGY | 3355 | AMERICAN SOCIETY FOR MICROBIOLOGY | 2013 | second_quarter | MED | Part B Clinical Laboratory Fee Schedule | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-07-15T13:13:33.107000-04:00 | ||
| 1407127 | PERSONALIZED MEDICINE COALITION a7c8b2a7-df36-4d11-b375-7c1ff7b18d70 | Q2 | PERSONALIZED MEDICINE COALITION | 40046362 | PERSONALIZED MEDICINE COALITION | 2013 | second_quarter | MED | Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-15T15:05:14.723000-04:00 | |
| 1407186 | AIR LIQUIDE USA LLC 97c7ebf1-d122-4b55-9597-94991360390e | Q2 | AIR LIQUIDE USA LLC | 400596821 | AIR LIQUIDE USA LLC | 2013 | second_quarter | MED | Regulatory and legislative matters related to medical gases and devices. | Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 136000 | 0 | 0 | 2013-07-15T15:19:39.333000-04:00 | |
| 1407326 | ROCK & ASSOCIATES ab512380-0599-4611-bb04-5888bafbbf95 | Q2 | ROCK & ASSOCIATES | 33545 | WOMEN'S INTERNATIONAL PHARMACY | 2013 | second_quarter | MED | S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 9375 | 0 | 0 | 2013-07-15T16:04:39.283000-04:00 | |
| 1407400 | ROCK & ASSOCIATES eb9acebc-db43-492f-be6e-cbb9d4930a4a | Q2 | ROCK & ASSOCIATES | 33545 | BRAIDWOOD MANAGEMENT, INC. | 2013 | second_quarter | MED | S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 9375 | 0 | 0 | 2013-07-15T16:35:09.837000-04:00 | |
| 1407419 | ROCK & ASSOCIATES 7094df03-d02a-4234-962a-3ea487490c0f | Q2 | ROCK & ASSOCIATES | 33545 | CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) | 2013 | second_quarter | MED | S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-07-15T16:48:23.153000-04:00 | ||
| 1407462 | ROCK & ASSOCIATES 498fa068-3053-4d32-ac5b-da816d24776b | Q2 | ROCK & ASSOCIATES | 33545 | DIAMONDBACK DRUGS | 2013 | second_quarter | MED | S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 6750 | 0 | 0 | 2013-07-15T16:57:42.273000-04:00 | |
| 1407501 | ROCK & ASSOCIATES 1d8d2c2f-fa5e-420d-a3b4-822ebda287c5 | Q2 | ROCK & ASSOCIATES | 33545 | VETERINARY PHARMACIES OF AMERICA, INC. | 2013 | second_quarter | MED | S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 9375 | 0 | 0 | 2013-07-15T17:12:02.090000-04:00 | |
| 1407541 | ROCK & ASSOCIATES b9b6673c-dc36-40e8-8941-fe4e67c331d7 | Q2 | ROCK & ASSOCIATES | 33545 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2013 | second_quarter | MED | S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 9375 | 0 | 0 | 2013-07-15T17:26:18.517000-04:00 | |
| 1407612 | THE OUTLAW GROUP 57e77e17-6700-4bce-893f-28180d590f3a | Q2 | THE OUTLAW GROUP | 46095 | AMERICAN TINNITUS ASSOCIATION | 2013 | second_quarter | MED | Legislation to ensure adequate funding of medical research on tinnitus. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-07-15T19:21:00.973000-04:00 | |
| 1407669 | GOLDBUG STRATEGIES LLC 5e71f954-82dc-48fe-8207-9bd56af00db5 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | COALITION FOR 21ST CENTURY MEDICINE | 2013 | second_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-16T09:30:26.097000-04:00 | |
| 1407679 | GOLDBUG STRATEGIES LLC ee90fa05-14c6-4694-ba36-50c61e19ddb2 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | LIFE TECHNOLOGIES/THERMO FISHER | 2013 | second_quarter | MED | regulation of medical devices, in vitro diagnostics and laboratory developed tests | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-07-16T09:37:28.887000-04:00 | ||
| 1407682 | GOLDBUG STRATEGIES LLC e4955a74-bc65-42e4-bdb3-2e0d5f560d1c | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | GENOMIC HEALTH INC. | 2013 | second_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-16T09:43:29.757000-04:00 | |
| 1408018 | WHITMER & WORRALL, LLC 66ba37cf-b1e9-416a-b425-bf7598df5c51 | Q2 | WHITMER & WORRALL, LLC | 292892 | NEURO KINETICS | 2013 | second_quarter | MED | Issues related to Traumatic Brain Injury (TBI). | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office | 20000 | 0 | 0 | 2013-07-16T12:06:16.307000-04:00 | |
| 1408560 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ba75dbde-082c-449b-86fb-13f5fec29400 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2013 | second_quarter | MED | Research in hematology. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2013-07-16T15:10:14.347000-04:00 | |
| 1408693 | INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS 8709778b-e1eb-42fe-b195-140f3cab42f1 | Q2 | INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS | 19822 | INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS | 2013 | second_quarter | MED | The IBEW along with the AFL-CIO lobbied congress against changing the Medicare eligibility age and means testing of the Medicare program. | Energy, Dept of,HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE | 256319 | 0 | 0 | 2013-07-16T15:32:09.097000-04:00 | |
| 1408764 | WEBMD HEALTH CORP. 0c3d4d17-7909-4976-b980-c6b142632b47 | Q2 | WEBMD HEALTH CORP. | 55473 | WEBMD HEALTH CORP | 2013 | second_quarter | MED | Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal healthcare reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records | SENATE | 30000 | 0 | 0 | 2013-07-16T15:47:35.367000-04:00 | |
| 1408794 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 318408bd-5de5-4cf1-ba50-6ab02e6fbf22 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2013 | second_quarter | MED | Appropriations and Authorization legislation for FY 2014 in health care HR 2397 Department of Defense Appropriations Bill 2014 and Senate bill HR 2216 Military Construction and Veterans Affairs Appropriations Bill FY2014 and Senate bill | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2013-07-16T15:52:49.083000-04:00 | |
| 1408865 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 847d1c4c-00e3-4677-89aa-e1bbf91400bd | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2013 | second_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2013-07-16T16:11:21.973000-04:00 | |
| 1408896 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0707585d-0848-482f-9e83-ad0fc4286b99 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2013 | second_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2013-07-16T16:13:30.910000-04:00 | |
| 1408919 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0d559b1f-b74b-460f-8345-925438756808 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION OF AMERICA'S BLOOD BANKS | 2013 | second_quarter | MED | Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-16T16:15:35.610000-04:00 | |
| 1409233 | FIRST STRATEGIC db35eb4f-8a79-42f4-9308-63fcfed3df6e | 2T | FIRST STRATEGIC | 91091 | PHOENIX CHILDREN'S HOSPITAL | 2013 | second_quarter | MED | Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2013-07-16T19:31:28.347000-04:00 | |
| 1409356 | SRI INTERNATIONAL 0724a954-4e93-4def-8551-8d32d0080fce | Q2 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2013 | second_quarter | MED | House and Senate FY14 Labor/HHS/Education Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-07-17T09:32:17.607000-04:00 | |
| 1409392 | BRET HEALY D/B/A RIVERBLUFF STRATEGIES 998f2091-fc1e-4108-924b-4aef5457bc77 | 2T | BRET HEALY D/B/A RIVERBLUFF STRATEGIES | 400581777 | HEALTH EDUCATION RESOURCES AND OUTREACH, INC | 2013 | second_quarter | MED | Activities in support of a grant application to the Centers for Disease Control for a Type 2 diabetes education and outreach program. | Health & Human Services, Dept of (HHS),SENATE | 10000 | 0 | 1 | 2013-07-17T09:43:30.153000-04:00 | |
| 1409525 | POLICY DIRECTIONS INC. fda71a80-c9d5-406a-beef-65f0872a9994 | Q2 | POLICY DIRECTIONS INC. | 31747 | CHARLES RIVER LABORATORIES | 2013 | second_quarter | MED | Pre-clinical research models and drug discovery, development and testing. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-17T10:49:45.973000-04:00 | |
| 1410240 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b5ba20d3-980b-4d17-990f-3806cfeb4f24 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | CRESCENDO BIOSCIENCE INC. | 2013 | second_quarter | MED | Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-17T14:46:43.630000-04:00 | |
| 1410260 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7c7bf9cf-7457-4a88-8609-19a925c82f53 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2013 | second_quarter | MED | Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1309: Health Information Technology Reform Act HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013 | Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 30000 | 0 | 0 | 2013-07-17T14:50:50.813000-04:00 | |
| 1410266 | MEHLMAN CONSULTING, INC. d966f71d-9f80-4f18-afea-fd1a4be53075 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | AMERICAN CLINICAL LABORATORY ASSOCIATION | 2013 | second_quarter | MED | Health reform law implementation issues including application of medical device tax to clinical laboratory tests and reform of laboratory fee schedule. In-office ancillary services exception to Stark Law. FDA oversight of laboratory-developed tests. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 80000 | 0 | 0 | 2013-07-17T14:52:54.263000-04:00 | |
| 1410280 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a526a867-8403-4b60-bbd6-88cbbd0fe0c1 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ONYX PHARMACEUTICALS | 2013 | second_quarter | MED | Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2013-07-17T14:55:03.030000-04:00 | |
| 1410310 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 766539f5-0ce2-4b1d-bac2-64e3799deff3 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | INTERNATIONAL MYELOMA FOUNDATION | 2013 | second_quarter | MED | Cancer Drug Coverage Parity Act, H.R. 1801 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-17T14:59:15.743000-04:00 | |
| 1410958 | INTERNATIONAL MYELOMA FOUNDATION 5a0fafa0-a55e-49de-9073-8ceb3955e3ed | Q2 | INTERNATIONAL MYELOMA FOUNDATION | 400595820 | INTERNATIONAL MYELOMA FOUNDATION | 2013 | second_quarter | MED | HR 1801, The Cancer Drug Coverage Parity Act | HOUSE OF REPRESENTATIVES,SENATE | 56000 | 0 | 0 | 2013-07-17T16:57:00.637000-04:00 | |
| 1411036 | UNIVERSITY OF ROCHESTER 5701a8e1-cbf1-4563-9f1d-49ffe857cc0e | Q2 | UNIVERSITY OF ROCHESTER | 301937 | UNIVERSITY OF ROCHESTER | 2013 | second_quarter | MED | Public Access S. 994, Digital Accountability and Transparency (DATA) Act | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-07-17T17:22:20.457000-04:00 | |
| 1411129 | THE CORMAC GROUP, LLC a61f4241-219b-423e-a2d4-ae22436463e2 | Q2 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2013 | second_quarter | MED | Appropriations, DOD, TBI research | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-17T18:02:07.930000-04:00 | |
| 1411237 | RAY C CULVER III 1fb7003e-2e23-4625-9633-91f4243e3e36 | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2013 | second_quarter | MED | Funding for the USDA ARS human nutrition centers in the FY14 Agricultural Appropriations bills, HR 2410 and S 1244. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-17T18:58:14.943000-04:00 | |
| 1411979 | THE PETRIZZO GROUP, INC. 8477f5f2-6306-46ca-b5f1-46df7e65c72b | Q2 | THE PETRIZZO GROUP, INC. | 305932 | VULCAN INC -- A PAUL G ALLEN COMPANY | 2013 | second_quarter | MED | Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2013-07-18T10:41:16.273000-04:00 | |
| 1412456 | AMERICAN ACADEMY OF FAMILY PHYSICIANS 0ab40c46-45b0-47a1-8b78-d117f38b3c81 | Q2 | AMERICAN ACADEMY OF FAMILY PHYSICIANS | 1342 | AMERICAN ACADEMY OF FAMILY PHYSICIANS | 2013 | second_quarter | MED | No Bill Number, ONDCP Drug Control Policy Plan Announcement, AAFP opposes CME mandates for opioid prescribing. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office | 547922 | 0 | 0 | 2013-07-18T11:55:46.623000-04:00 | |
| 1412631 | THORN RUN PARTNERS 44fec034-b7ef-4d35-9ba3-672f64399c54 | Q2 | THORN RUN PARTNERS | 400534596 | ABBOTT LABORATORIES | 2013 | second_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES | 40000 | 0 | 0 | 2013-07-18T12:23:49.757000-04:00 | |
| 1412649 | WASHINGTON UNIVERSITY IN ST. LOUIS 90d906a0-e7d9-42a7-bdea-3b216de63bab | Q2 | WASHINGTON UNIVERSITY IN ST. LOUIS | 40031264 | WASHINGTON UNIVERSITY IN ST LOUIS | 2013 | second_quarter | MED | General advocacy for NIH research, genomics research, and improved conflict of interest policies. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-07-18T12:28:13.207000-04:00 | |
| 1412684 | O'NEILL AND ASSOCIATES 57106e4a-4b52-40ff-9ee6-8ee4dfc1ab9c | Q2 | O'NEILL AND ASSOCIATES | 73134 | THE JETT FOUNDATION | 2013 | second_quarter | MED | FDA Issues. Seeking accelerated approval for breakthrough medical treatments to treat Duchenne Muscular Dystrophy | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-07-18T12:39:10.387000-04:00 | |
| 1412714 | THORN RUN PARTNERS becc17b7-2f7c-48db-a9fc-0c5ec60deb8a | Q2 | THORN RUN PARTNERS | 400534596 | CHILDRENS HOSPITAL COLORADO | 2013 | second_quarter | MED | Issues related to clinical research. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-07-18T12:46:22.033000-04:00 | |
| 1412915 | ELI LILLY AND COMPANY b9e02363-d45d-489a-824c-41f27c0ac84f | Q2 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2013 | second_quarter | MED | NCATS | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1965000 | 0 | 0 | 2013-07-18T13:24:37.947000-04:00 | |
| 1412942 | THORN RUN PARTNERS b43be892-ad01-45b3-8134-8a65ba9c4e74 | Q2 | THORN RUN PARTNERS | 400534596 | NOVARTIS CORPORATION | 2013 | second_quarter | MED | Issues related to biologics. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-18T13:27:50.837000-04:00 | |
| 1413327 | PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE e73b7a24-f010-48d9-9cdf-dca122c05c48 | Q2 | PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE | 400382759 | PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE | 2013 | second_quarter | MED | HR 1150-Preservation of Antibiotics for Medical Treatment Act of 2013. | HOUSE OF REPRESENTATIVES,SENATE | 25208 | 0 | 0 | 2013-07-18T14:44:34.603000-04:00 | |
| 1414038 | PRIME POLICY GROUP ce92342b-a155-42c8-b0e2-2e1b5649a56c | Q2 | PRIME POLICY GROUP | 400532589 | VERAX BIOMEDICAL, INC. | 2013 | second_quarter | MED | Blood Safety | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-18T16:04:55.477000-04:00 | |
| 1414181 | ALERE INC. ef640e08-5563-462b-8a3d-7ded2d061df4 | Q2 | ALERE INC. | 400647952 | ALERE INC. | 2013 | second_quarter | MED | Development of new and innovative in-vitro diagnostic tests. | HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS) | 159000 | 0 | 0 | 2013-07-18T16:20:48.043000-04:00 | |
| 1414430 | MEDEXPERT CONSULTING, INC. fb2d24d2-448b-4887-b6d9-7cc762fa891c | Q2 | MEDEXPERT CONSULTING, INC. | 401061992 | BIOCRYST PHARMACEUTICALS, INC. | 2013 | second_quarter | MED | Funding for development of medical countermeasures directed against bioterrorism agents that pose a significant threat to public health and national security. | Defense Threat Reduction Agency (DTRA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-18T16:51:46.377000-04:00 | |
| 1415321 | GROUP HEALTH COOPERATIVE d6736593-ca19-4bb5-973e-16c1c047060a | Q2 | GROUP HEALTH COOPERATIVE | 17022 | GROUP HEALTH COOPERATIVE | 2013 | second_quarter | MED | Health systems and medical research topics. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Personnel Management (OPM),SENATE,White House Office | 120000 | 0 | 0 | 2013-07-19T00:40:22.780000-04:00 | |
| 1415329 | W STRATEGIES, LLC 463c61de-7e46-4bcd-acb5-daaea107dfa7 | Q2 | W STRATEGIES, LLC | 400605842 | 23ANDME, INC. | 2013 | second_quarter | MED | Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-19T01:45:27.840000-04:00 | |
| 1415557 | VAN SCOYOC ASSOCIATES 0933be56-e97e-4ecf-bbdd-4c98e9e1338b | Q2 | VAN SCOYOC ASSOCIATES | 39837 | STERILUCENT, INC. | 2013 | second_quarter | MED | H.R.5856, Department of Defense Appropriations Act, FY2013, Low temperature portable sterilization devices related issues. H.R.2397, Department of Defense Appropriations Act, FY2014, Low temperature portable sterilization devices related issues. | Army, Dept of (Other),Navy, Dept of,U.S. Marines | 20000 | 0 | 0 | 2013-07-19T07:50:41.620000-04:00 | |
| 1415756 | GEORGETOWN UNIVERSITY 17e0e29b-070f-4c39-9479-d7eb7bb7184b | Q2 | GEORGETOWN UNIVERSITY | 62016 | GEORGETOWN UNIVERSITY | 2013 | second_quarter | MED | Regulatory issues involved in domestic research on health benefits of probiotics in yogurt. | Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE | 20000 | 0 | 0 | 2013-07-19T09:27:38.013000-04:00 | |
| 1416000 | CROSSROADS STRATEGIES, LLC c6323b3a-d14d-4141-bd67-75f1f61043f0 | Q2 | CROSSROADS STRATEGIES, LLC | 400531586 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2013 | second_quarter | MED | S.644, PACT Act; issues related to preventing abuse or diversion of over-the-counter drugs; Food and Drug Administration Safety and Innovation Act, Public Law No: 112-144; issues related to insuring access to over-the-counter drugs. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-07-19T10:06:09.170000-04:00 | |
| 1416020 | AMERICAN ACADEMY OF PEDIATRICS 6d5e5a39-0a91-44c4-8548-bbec1d04482f | Q2 | AMERICAN ACADEMY OF PEDIATRICS | 1397 | AMERICAN ACADEMY OF PEDIATRICS | 2013 | second_quarter | MED | Medical Countermeasures for Children National Children's Study Inclusion of Children in Biomedical Research | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Treasury, Dept of,White House Office | 112573 | 0 | 0 | 2013-07-19T10:09:18.200000-04:00 | |
| 1416141 | K&L GATES, LLP 759f3b97-3902-45c6-b5d8-a9f8aa70d788 | Q2 | K&L GATES, LLP | 32098 | SMITS SPEIDELL CONSULTING | 2013 | second_quarter | MED | Yet to be introduced: A bill to amend the Internal Revenue Code of 1986 to broaden the special rules for certain governmental plans under section 105(j) to include plans established by political subdivisions. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-07-19T10:27:00.433000-04:00 | |
| 1416370 | BAKER BOTTS, L.L.P. 870f5f39-7a77-4b4e-aa04-41ab1d7a16fe | Q2 | BAKER BOTTS, L.L.P. | 5118 | SOUTHERN METHODIST UNIVERSITY | 2013 | second_quarter | MED | Funding of neurophotonics research for prosthetic devices. | HOUSE OF REPRESENTATIVES | 50000 | 0 | 0 | 2013-07-19T10:56:38.350000-04:00 | |
| 1416710 | TURNER & GOSS LLP bf132d68-aa2f-49b1-848f-ef2ff57ec5e7 | Q2 | TURNER & GOSS LLP | 316310 | CANCER LEADERSHIP COUNCIL | 2013 | second_quarter | MED | S. 957, Drug Supply Chain Security Act H.R. 1919, Safeguarding America's Pharmaceuticals Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-07-19T11:28:55.557000-04:00 | ||
| 1417120 | OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC acfd5c5d-13d9-4264-a9cd-d26acb1f57cd | Q2 | OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC | 30212 | ASSOCIATION OF MEDICAL DEVICE REPROCESSORS | 2013 | second_quarter | MED | Monitor and advocate on legislation regarding third party medical device reprocessing. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-07-19T12:02:27.720000-04:00 | ||
| 1417432 | FAEGRE DRINKER BIDDLE & REATH LLP 87500f71-cc7a-4cc9-b6f4-c6fce7e80a38 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | HARM REDUCTION COALITION | 2013 | second_quarter | MED | Overdose Fatality Prevention Efforts | Food & Drug Administration (FDA),SENATE | 10000 | 0 | 0 | 2013-07-19T12:32:05.883000-04:00 | |
| 1417503 | FAEGRE DRINKER BIDDLE & REATH LLP bdbb9c1d-b4a4-4c36-b9d2-6f37e44069db | 2T | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | NATIONAL PSORIASIS FOUNDATION | 2013 | second_quarter | MED | Psoriasis Data Collection. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 1 | 2013-07-19T12:39:32.110000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);